4.2
慢性阻塞性肺病 II:病理生理学
慢性阻塞性肺病 (COPD) 的病理生理学复杂且多面，涉及生理过程的复杂相互作用。了解这些机制对于有效管理和治疗 COPD 至关重要。以下是 COPD 病理生理学中关键要素的深入介绍:
慢性炎症
- 吸入刺激物:吸入刺激物，尤其是香烟烟雾，是 COPD 炎症的主要原因。其他刺激物包括环境灰尘、化学物质和…
慢性阻塞性肺疾病（COPD）主要由长期接触刺激物（如香烟烟雾、粉尘或空气污染）引起的慢性气道炎症所致。
炎症细胞（包括淋巴细胞、巨噬细胞和中性粒细胞）侵入气道壁，释放白三烯 和细胞因子等有害介质。
这些炎性细胞产生的吸入性颗粒物和氧化剂会加重炎症。
氧化剂可抑制保护肺组织免受降解的抗蛋白酶化合物。
同时，它们会增加降解肺组织的蛋白酶的活性。
这种失衡会破坏蛋白酶与抗蛋白酶之间的自然平衡，导致肺泡退化和肺弹性丧失。
因此，气道变窄，阻碍气流，促使黏液过度分泌，并导致肺部液体积聚。
在慢性阻塞性肺疾病（COPD）中，慢性炎症引发氧化应激，释放自由基，导致肺组织损伤，进而形成肺大疱并破坏肺泡壁，损害气体交换功能。
View the full transcript and gain access to JoVE Core videos
Q1: What causes chronic airway inflammation in COPD?
COPD develops from chronic exposure to irritants like cigarette smoke, dust, and air pollution. These irritants trigger inflammatory cells—lymphocytes, macrophages, and neutrophils—to infiltrate airway walls and release harmful mediators such as leukotrienes and cytokines. This perpetuates ongoing inflammation and progressive lung damage characteristic of the disease.
Q2: How does the protease-antiprotease imbalance damage lung tissue in COPD?
Oxidants from cigarette smoke impair antiproteases like alpha-1 antitrypsin that normally protect lung tissue. Simultaneously, oxidants increase protease activity, particularly elastase, which degrades extracellular matrix components. This imbalance causes destruction of alveolar walls and lung parenchyma, leading to emphysema and loss of lung elasticity.
Q3: What role do free radicals play in COPD pathophysiology?
Chronic inflammation generates reactive oxygen species (ROS) like superoxide anions and hydroxyl radicals from cigarette smoke and inflammatory cells. These free radicals damage cellular structures, proteins, lipids, and DNA, further promoting inflammation and lung tissue deterioration. This oxidative stress perpetuates the cycle of tissue destruction in COPD.
Q4: How does airway narrowing occur in COPD?
Chronic inflammation causes structural changes and constriction in airways, reducing airflow. Mucus hypersecretion and mucosal edema exacerbate narrowing, while smooth muscle constriction further impedes airflow. Additionally, increased vascular permeability from inflammation leads to fluid accumulation in lungs, contributing to obstruction and airway blockage.
Q5: What structural changes occur in the lungs during COPD?
Ongoing tissue destruction causes alveolar enlargement and bullae formation—large air pockets within lung tissue. Destruction of alveolar walls reduces surface area for gas exchange, impairing oxygen uptake and carbon dioxide elimination. These structural changes decrease lung compliance and elasticity, leading to reduced oxygen uptake and shortness of breath.
Q6: How do inflammatory mediators perpetuate lung damage in COPD?
Inflammatory cells release cytokines, leukotrienes, and other mediators that perpetuate the inflammatory response. These mediators recruit additional inflammatory cells and sustain the release of proteases and oxidants. This creates a self-perpetuating cycle of inflammation and tissue destruction that characterizes COPD progression.
Q7: Why is gas exchange impaired in COPD?
Destruction of alveolar walls reduces the surface area available for oxygen and carbon dioxide exchange. Combined with fluid accumulation and airway obstruction, these structural changes impair gas exchange efficiency. Understanding these mechanisms is essential for developing effective chronic obstructive pulmonary disease management strategies.